XML 105 R89.htm IDEA: XBRL DOCUMENT v3.25.4
LONG-TERM COMPENSATION (Details)
$ / shares in Units, shares in Thousands
12 Months Ended
Dec. 31, 2025
USD ($)
plan
$ / shares
shares
Dec. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of share-based compensation plans covering employees, officers and directors | plan 2    
Expiration period of stock options 10 years    
Stock Option, Intrinsic Value      
Proceeds from stock option exercises | $ $ 110,863,000 $ 26,052,000 $ 1,736,000
Intrinsic value for options exercised | $ $ 14,043,000    
Nonvested Restricted Stock and Restricted Stock Units, Weighted Average Grant Date Fair Value      
Share-based compensation arrangement, risk free rate 4.29% 4.09% 3.84%
Share-based compensation arrangement, volatility 42.20% 42.00% 41.30%
Employee Benefit Plan      
Maximum 401(K) plan contribution by employer as a percent of employee's salary 4.00%    
Aggregate employer 401(K) plan contribution during the period | $ $ 2,400,000 $ 2,100,000 $ 2,000,000.0
Employee Stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares available for future issuance (in shares) 2,800    
Number of shares authorized for issuance (in shares) 3,000    
Nonvested Restricted Stock and Restricted Stock Units, Weighted Average Grant Date Fair Value      
Number of shares purchased (in shares) 200    
Employee Stock | Director      
Nonvested Restricted Stock and Restricted Stock Units, Weighted Average Grant Date Fair Value      
Discount related to the Employee Stock Purchase Plan 95.00%    
Employee Stock | Employee      
Nonvested Restricted Stock and Restricted Stock Units, Weighted Average Grant Date Fair Value      
Discount related to the Employee Stock Purchase Plan 90.00%    
Stock Options      
Stock Option, Shares      
Outstanding at the beginning of the period (in shares) 2,631    
Options exercised (in shares) (1,750)    
Outstanding at the end of the period (in shares) 483 2,631  
Exercisable at the end of the period (in shares) 483    
Stock Option, Weighted Average Exercise Price      
Outstanding at the beginning of the period (in dollars per share) | $ / shares $ 63.89    
Options exercised (in dollars per share) | $ / shares 63.35    
Outstanding at the end of the period (in dollars per share) | $ / shares 64.17 $ 63.89  
Exercisable at the end of the period (in dollars per share) | $ / shares $ 64.17    
Stock Option, Weighted Average Remaining Contractual Life (years)      
Outstanding at the end of the period (in years) 10 months 24 days    
Exercisable at the end of the period (in years) 10 months 24 days    
Stock Option, Intrinsic Value      
Outstanding at the end of the period | $ $ 6,380,000    
Exercisable at the end of the period | $ 6,380,000    
Proceeds from stock option exercises | $ 110,900,000 $ 26,100,000 1,700,000
Intrinsic value for options exercised | $ 14,000,000 1,200,000  
Nonvested Restricted Stock and Restricted Stock Units, Weighted Average Grant Date Fair Value      
Deferred income tax expense (benefit) | $ $ 0    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period (398)    
Options exercised (in dollars per share) | $ / shares $ 65.94    
Stock Options | General and administrative expenses      
Stock Option, Intrinsic Value      
Compensation cost | $ $ 0 0 0
Restricted Stock or Restricted Stock Units      
Nonvested Restricted Stock and Restricted Stock Units, Weighted Average Grant Date Fair Value      
Unrecognized compensation cost related to nonvested awards | $ $ 22,700,000    
Weighted average period over which cost is recognized 1 year 8 months 8 days    
Intrinsic value for options vested during period | $ $ 38,800,000 32,700,000 25,000,000.0
Restricted Stock or Restricted Stock Units | General and administrative expenses      
Stock Option, Intrinsic Value      
Compensation cost | $ $ 38,700,000 $ 30,900,000 30,400,000
Restricted Stock      
Nonvested Restricted Stock and Restricted Stock Units, Shares      
Nonvested at the beginning of the period (in shares) 51    
Granted (in shares) 0    
Vested (in shares) (51)    
Forfeited (in shares) 0    
Nonvested at the end of the period (in shares) 0 51  
Nonvested Restricted Stock and Restricted Stock Units, Weighted Average Grant Date Fair Value      
Nonvested at the beginning of the period (in dollars per share) | $ / shares $ 49.88    
Granted (in dollars per share) | $ / shares 0    
Vested (in dollars per share) | $ / shares 49.88    
Forfeited (in dollars per share) | $ / shares 0    
Nonvested at the end of the period (in dollars per share) | $ / shares $ 0 $ 49.88  
Restricted Stock Units      
Nonvested Restricted Stock and Restricted Stock Units, Shares      
Nonvested at the beginning of the period (in shares) 1,301    
Granted (in shares) 796    
Vested (in shares) (649)    
Forfeited (in shares) (61)    
Nonvested at the end of the period (in shares) 1,387 1,301  
Nonvested Restricted Stock and Restricted Stock Units, Weighted Average Grant Date Fair Value      
Nonvested at the beginning of the period (in dollars per share) | $ / shares $ 52.39    
Granted (in dollars per share) | $ / shares 62.28    
Vested (in dollars per share) | $ / shares 54.87    
Forfeited (in dollars per share) | $ / shares 51.67    
Nonvested at the end of the period (in dollars per share) | $ / shares $ 56.90 $ 52.39  
Performance-Based Stock Units      
Nonvested Restricted Stock and Restricted Stock Units, Weighted Average Grant Date Fair Value      
Share-based compensation arrangement, granted in period, fair value | $ $ 49,200,000 $ 35,600,000 $ 30,100,000
Performance-Based Stock Units | Director      
Nonvested Restricted Stock and Restricted Stock Units, Weighted Average Grant Date Fair Value      
Vesting period 3 years    
Minimum | Restricted Stock or Restricted Stock Units | Director      
Nonvested Restricted Stock and Restricted Stock Units, Weighted Average Grant Date Fair Value      
Vesting period 1 year    
Minimum | Restricted Stock      
Nonvested Restricted Stock and Restricted Stock Units, Weighted Average Grant Date Fair Value      
Share-based compensation arrangement, fair market value, expense term 3 years    
Maximum | Restricted Stock or Restricted Stock Units | Employee      
Nonvested Restricted Stock and Restricted Stock Units, Weighted Average Grant Date Fair Value      
Vesting period 3 years    
Maximum | Restricted Stock      
Nonvested Restricted Stock and Restricted Stock Units, Weighted Average Grant Date Fair Value      
Share-based compensation arrangement, fair market value, expense term 4 years    
Maximum | Performance-Based Stock Units      
Nonvested Restricted Stock and Restricted Stock Units, Weighted Average Grant Date Fair Value      
Share-based compensation arrangement, expected term 3 years    
2022 Incentive Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares available for future issuance (in shares) 10,000    
Number of shares authorized for issuance (in shares) 11,400    
Executive Deferred Stock Compensation Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of share-based compensation plans for executive officers | plan 1    
Nonemployee Directors' Deferred Stock Compensation Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of share-based compensation plans for directors | plan 1    
Number of shares available for future issuance (in shares) 300    
Number of shares authorized for issuance (in shares) 600